Learn More
Medchemexpress LLC Epoprostenol sodium | 61849-14-7 | 98.03% | C20H31NaO5 | 5 MG

Supplier: Medchemexpress LLC HYA0126A5MG
Epoprostenol sodium is a synthetic form of prostacyclin (prostaglandin I2) that is globally approved for treating Pulmonary arterial hypertension (PAH). It is also utilized in pulmonary hypertension and transplantation, acting as a potent inhibitor of platelet aggregation.
- Synthetic form of prostacyclin (prostaglandin I2)
- Approved for treating pulmonary arterial hypertension (PAH)
- Utilized in pulmonary hypertension and transplantation
- Functions as a potent inhibitor of platelet aggregation
- Induces apoptosis in PAH-PASMCs
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.